. . . . . . . . . . . . . . . . . . "a(SCHEM:Methylnaltrexone) -| (p(HGNC:F2) -> bp(GOBP:\"regulation of vascular permeability\"))" . "p(HGNC:F2) -> bp(GOBP:\"regulation of vascular permeability\")" . "Approximately 61,000 statements." . "Copyright (c) 2011-2012, Selventa. All rights reserved." . "BEL Framework Large Corpus Document" . . "20131211" . "methylnaltrexone (MNTX), a mu opioid receptor (mOP-R) antagonist, has been reported to provide barrier protection against edemagenic agonists such as thrombin and lipopolysaccharide (LPS) via inhibition of S1P3 receptor activation (Singleton et al., 2007)." . . "Selventa" . . . . "2014-07-03T14:33:27.860+02:00"^^ . . .